12 Health Care Stocks Moving In Thursday's Intraday Session
Celularity shares are trading higher after the company announced an additional U.S.-based manufacturing collaboration under which Celularity will undertake activities to establish U.S. production of Dezawa MuseCells at Celularity’s Florham Park, New Jersey facility.
Celularity partners with MuseCell Innovations on U.S. manufacturing for Dezawa MuseCell platform
Celularity risks Nasdaq noncompliance over late SEC quarterly filings
Celularity Provides Update Regarding Nasdaq Listing Compliance | CELU Stock News
Nexgel’s Celularity Deal: Execution, Integration, and Profitability Risks from $13.3 Million Biomaterials Acquisition